Clear Street’s Cardinal Health CAH Stock Holding History

Clear Street’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-143	Closed	-$10K	–	1073
2022 Q3	$10K	Buy	+143	New	+$9.06K	﹤0.01%	609

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Clear Street's CAH Position: Q4 2022 in Review

Clear Street sold out of Cardinal Health (CAH) in Q4 2022, closing a stake of 143 shares — an estimated $10K sold.

Clear Street first reported a position in CAH in Q3 2022 and held it in 1 quarter. The position peaked at $10K in Q3 2022. 930 funds tracked by Wall St. Rank hold CAH as of Q4 2022.

Clear Street reported no remaining Cardinal Health position as of Q4 2022 after selling out during the quarter.
Clear Street sold 143 Cardinal Health shares in Q4 2022, an estimated $10K.
Clear Street first reported a position in Cardinal Health in Q3 2022 and held it in 1 quarter.
Clear Street's Cardinal Health position peaked at $10K in Q3 2022.
930 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2022.

Based on Clear Street's 13F filing for Q4 2022, filed 13 Feb 2023.